Acetyl Ceramide

Acetyl Ceramide

SCHEMBL12648655

CCCCCCCCCCCCC/C=C/[C@@H](O)C(CO)NC(C)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 1.00
▸ CYP2D6 P10635 3/20 1.00
▸ MAPK1 P28482 3/20 1.00
▸ TP53 P04637 2/20 1.00
▸ CYP1A2 P05177 2/20 1.00
▸ CYP2C9 P11712 2/20 1.00
▸ CYP2C19 P33261 2/20 1.00
▸ CETP P11597 7/20 0.75
▸ MEN1 O00255 4/20 0.75
▸ KMT2A Q03164 4/20 0.75
▸ THRB P10828 3/20 0.75
▸ ASAH1 Q13510 2/20 0.73
▸ ASAH2 Q9NR71 2/20 0.71
▸ ALDH1A1 P00352 2/20 0.65
▸ KDM4E B2RXH2 1/20 0.65
▸ SPHK2 Q9NRA0 4/20 0.55
▸ SPHK1 Q9NYA1 4/20 0.55
▸ GMNN O75496 2/20 0.55
▸ LMNA P02545 2/20 0.55
▸ GLA P06280 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetyl Ceramide SCHEMBL21067736 1.00 MAPT (1.00) MAPTCYP2D6MAPK1TP53CYP1A2
Acetyl Ceramide SCHEMBL16892474 1.00 MAPT (1.00) MAPTCYP2D6MAPK1TP53CYP1A2
Acetyl Ceramide SCHEMBL29756043 1.00 MAPT (1.00) MAPTCYP2D6MAPK1TP53CYP1A2
Acetyl Ceramide SCHEMBL58536 1.00 MAPT (1.00) MAPTCYP2D6MAPK1TP53CYP1A2
Acetyl Ceramide SCHEMBL1191825 1.00 MAPT (1.00) MAPTCYP2D6MAPK1TP53CYP1A2
Acetyl Ceramide SCHEMBL31683764 1.00 MAPT (1.00) MAPTCYP2D6MAPK1TP53CYP1A2
Acetyl Ceramide SCHEMBL29144648 1.00 MAPT (1.00) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL12330743 1.00 MAPT (1.00) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL12764186 0.90 MAPT (0.81) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL8622716 0.88 MAPT (0.78) MAPTCYP2D6MAPK1TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034798-B2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions CAPROTEC BIOANALYTICS GMBH (DE) 2015-05-19 — — US disclosed
US-8569481-B2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions PHARMACEUTICALS, INC. (US) 2013-10-29 — — US disclosed
US-20110118136-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions KOESTER HUBERT 2011-05-19 — — US disclosed
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions HK PHARMACEUTICALS, INC. 2010-11-25 — — US disclosed
US-20100248264-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions HK PHARMACEUTICALS, INC. 2010-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118136-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions PTMS, QPCTL, SRMS MAPT 3419/4885CYP2D6 4323/4885MAPK1 4167/4885
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions CHLSN, PTMS, SRMS MAPT 2601/4885CYP2D6 4202/4885MAPK1 3918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback